AGL40.03▲ 0.02 (0.00%)AIRLINK129.31▲ 2.31 (0.02%)BOP6.8▲ 0.11 (0.02%)CNERGY4.64▲ 0.13 (0.03%)DCL8.63▼ -0.01 (0.00%)DFML40.95▼ -0.09 (0.00%)DGKC85.74▲ 0.13 (0.00%)FCCL33▼ -0.11 (0.00%)FFBL66.53▲ 0.43 (0.01%)FFL11.46▼ -0.09 (-0.01%)HUBC110.58▼ -0.53 (0.00%)HUMNL14.63▼ -0.19 (-0.01%)KEL5.24▲ 0.07 (0.01%)KOSM8.11▲ 0.45 (0.06%)MLCF40.07▼ -0.14 (0.00%)NBP60.51▲ 0 (0.00%)OGDC195.47▲ 1.37 (0.01%)PAEL27.1▲ 0.38 (0.01%)PIBTL7.64▲ 0.27 (0.04%)PPL155.82▲ 2.03 (0.01%)PRL27.37▲ 1.16 (0.04%)PTC18.56▲ 1.38 (0.08%)SEARL85.1▼ -0.5 (-0.01%)TELE7.9▲ 0.33 (0.04%)TOMCL34.88▲ 0.49 (0.01%)TPLP9.22▲ 0.4 (0.05%)TREET16.81▼ -0.01 (0.00%)TRG62.86▲ 0.31 (0.00%)UNITY27.75▲ 0.46 (0.02%)WTL1.3▲ 0 (0.00%)

Virus vaccine approval

Share
Tweet
WhatsApp
Share on Linkedin
[tta_listen_btn]

Web Desk

Regulators that normally work within their own countries or regions, will likely harmonize efforts on potential COVID-19 vaccines, said WHO chief scientist Soumya Swaminathan. She added that it would be to speed up their approvals once they become available. Swaminathan, answering questions on social media platforms, also said testing vaccines for safety and efficacy – usually a years-long process – could be accelerated to just six months in the midst of the pandemic, if data satisfied regulators that they have enough information to issue approvals. “Whilst speed is important, it cannot be at the cost of compromising on the safety or the efficacy standards that one is setting for oneself,” she said.

Related Posts

Get Alerts